(Q39613843)

13 September 2017

1 reference

title

Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy (English)

1 reference

13 September 2017

0 references

0 references

Dische S

1

1 reference

13 September 2017

1 February 1985

1 reference

Radiotherapy and Oncology

13 September 2017

1 reference

13 September 2017

3

1 reference

13 September 2017

97-115

1 reference

13 September 2017

2

1 reference

HYDRATED ELECTRONS AND RADIOBIOLOGICAL SENSITISATION

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Care with radiosensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Pre-therapeutic experiments with the fast neutron beam from the Medical Research Council cyclotron. V. Comparison between the oxygen enhancement ratios for neutrons and x-rays, as observed with Escherichia coli B

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

The quantitative response of human tumours to radiation and misonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Experience in the radical radiotherapy of cancer in the bilharzial bladder: The use of misonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Clinical trials of radiosensitizers: What should we expect?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

The use of drugs which deplete intracellular glutathione in hypoxic cell radiosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

High-pressure oxygen and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Initial pharmacology and toxicology of intravenous desmethylmisonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Human studies with "high dose" metronidazole: a non-toxic radiosensitizer of hypoxic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Skin reaction — a quantitative system for measurement of radiosensitisation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Clinical testing of the radiosensitiser Ro-07-0582 II. Radiosensitisation of normal and hypoxic skin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

A drug for improved radiosensitization in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Neurotoxicity with desmethylmisonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Carcinoma of the cervix--anaemia, radiotherapy and hyperbaric oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Radiobiological hypoxia of a transplanted rat tumour and the effect of treatment with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Hypoxic Sensitizers: Radiobiological Studies at the Cellular Level

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Misonidazole and radiotherapy in lung cancer: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

The Medical Research Council trial of misonidazole in carcinoma of the uterine cervix. A report from the MRC Working Party on misonidazole for cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Misonidazole Combined with Split-Course Radiotherapy in the Treatment of Invasive Carcinoma of the Larynx and the Pharynx - A Preliminary Report of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Treatment of bladder carcinoma with irradiation combined with misonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

A report on misonidazole in randomized trial in locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Misonidazole and irradiation in the treatment of high-grade astrocytomas: Further report of the Vienna study group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Mechanisms of hypoxic cell radiosensitization and the development of new sensitizers.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

A phase I clinical study of Nimorazole as a hypoxic radiosensitizer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Radiosensitization by non-nitro compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

In vivo assessment of basic 2-nitroimidazole radiosensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2885%2980015-3

7 January 2021

10.1016/S0167-8140(85)80015-3

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

3157206